Trials / Completed
CompletedNCT02390037
Pipeline™ Flex Embolization Device With Shield Technology™ Clinical Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Medtronic Neurovascular Clinical Affairs · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to assess the incidence of safety outcomes in patients treated with Pipeline™ Flex embolization device with Shield Technology™.
Conditions
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-11-04
- Completion
- 2016-11-04
- First posted
- 2015-03-17
- Last updated
- 2019-02-01
Locations
7 sites across 6 countries: Belgium, Germany, Greece, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02390037. Inclusion in this directory is not an endorsement.